# Ramelteon 8 mg Tablets Specified Drug-use Survey: <Long-term Survey on Insomnia Accompanied by Difficulty Falling Asleep> - Transitional Survey From the Preceding Drug-use Survey -

> **NCT02153086** · — · COMPLETED · sponsor: **Takeda** · enrollment: 236 (actual)

## Conditions studied

- Insomnia

## Interventions

- **DRUG:** Ramelteon

## Key facts

- **NCT ID:** NCT02153086
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 236 (ACTUAL)
- **Last updated:** 2016-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02153086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02153086, "Ramelteon 8 mg Tablets Specified Drug-use Survey: <Long-term Survey on Insomnia Accompanied by Difficulty Falling Asleep> - Transitional Survey From the Preceding Drug-use Survey -". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02153086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*